Pharmacy and Provider Collaboration

EP: 1.Comparing Biologics and Biosimilars

EP: 2.Biosimilar Utilization and Inventory Management

EP: 3.Operationalizing Biosimilars in Specialty Pharmacies

EP: 4.Advice for States that Require Prior Prescriber Approval for Substitution

EP: 5.Key Factors to Consider when Switching to Biosimilars

Now Viewing

EP: 6.Pharmacy and Provider Collaboration

EP: 7.Biosimilar Copay Programs

Video content above is prompted by the following:

• How can pharmacy teams better collaborate with providers to support the switch to biosimilars, and what strategies can be used to educate both providers and the pharmacy team? What practices have you seen be successful?